We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Implant Coating Material Releases Antibiotics in Response to Bacterial Invasion

By HospiMedica International staff writers
Posted on 05 Mar 2024

Artificial joints, often used to treat degenerative arthritis, create the challenge of bacterial infections. More...

These infections can undermine the stability of the implant and lead to various complications, including those caused by antibiotic-resistant bacteria. These bacteria often trigger recurring infections even after antibiotic treatment, necessitating further procedures. Now, researchers have designed a functional implant coating material that promptly releases antibiotics in reaction to changes in the body's environment as a result of bacterial infection.

Developed by a collaborative research team comprising scientists from Pohang University of Science and Technology (POSTECH, Gyeongbuk, Korea), the coating is based on mussel adhesion proteins. Their research specifically focused on DOPA, an amino acid key to mussel adhesion. DOPA forms strong bonds with metal ions, particularly iron, but these bonds weaken when the acidity (pH) level drops. Given that bacterial invasion alters the body's pH, the team designed the coating that contains antibiotics under normal conditions, but releases them rapidly when infection-induced acidification occurs. It releases 70% of the antibiotics within eight hours, effectively eliminating the bacteria.

The material also exhibits remarkable durability, maintaining its antibacterial efficacy even during the four weeks of bone regeneration phase following an implant procedure. The amount of antibiotics released by the material matches the severity of the bacterial infection. The researchers validated the antibacterial efficacy of the coating material based on varying bacterial concentrations. Importantly, the bond between DOPA and iron ions proved highly resistant to external physical stimuli, making it resistant to abrasion and mechanical loads during the implantation process.

"The immediate and sustained antimicrobial effect of the adhesive implant coating material has the potential to significantly enhance the success rate of implant procedures," said Professor Hyung Joon Cha from POSTECH who led the study.

Related Links:
POSTECH


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.